baber/WOPTO huggingface dataset:
Patent DK-0435785-T3 (DK)
Inventor: CHARMOT DOMINIQUE
IPC: C08G77/20
Filed: 1990-12-20
Granted: 1994-08-29
Abstract: Magnetisable composite microspheres made up of a core consisting of magnetisable fillers distributed uniformly in a lattice of a polysilsesquioxane (SiVi) containing ethylenic unsaturations and a skin made of a crosslinked organosilicon polymer derived from the hydrosilylation of an organohydropolysiloxane (SiH) with the ethylenically unsaturated groups of the polysilsesquioxane SiVi. 
<??>They are obtained by dispersion in a solvent of an aqueous suspension of magnetisable fillers not coated with dispersing agent, dissolving of an alkoxysilane or of an alkoxysiloxane containing ethylenic unsaturations, polycondensation to a polysilsesquioxane SiVi, removal of water, dissolving of the SiH polymer in the organic phase, crosslinking, removal of water, isolation of the microspheres and optionally redispersion in water. 
<??>Use as active support in biology.
Patent DK-0576424-T3 (DK)
Inventor: ROSHOLM PETER
IPC: C12P19/14
Filed: 1991-06-14
Granted: 1996-08-05
Abstract: The effect of a polysaccharide hydrolase is increased by incorporation of a water-soluble polymer of one or more monomers selected from the group of vinyl pyrrolidone, vinyl alcohol, acrylamide and soluble acrylates into the reaction system in dissolved form.
Patent DK-0523335-T3 (DK)
Inventor: FROESCHKE REINHARD
IPC: B01J2/20
Filed: 1992-05-08
Granted: 1995-03-27
Abstract: A rotary drum assembly contains a flowable material and includes peripheral openings through which the material can flow to form pieces of the material on a belt traveling beneath the drum assembly. A guide contacts the outer periphery of the drum assembly for pressing residual material back into the openings. The guide can be pivoted away from the drum assembly for servicing, and can be adjusted to different positions around the circumference of the drum assembly.
Patent DK-0550841-T3 (DK)
Inventor: SCHULZ HARALD DR
IPC: E04B2/36
Filed: 1992-12-09
Granted: 1998-04-14
Abstract: In order to improve the heat-insulating properties of facades in the region of the spandrel, the invention proposes a facade structure in which there are arranged, in an uninterrupted manner in the entire spandrel region, in particular also between the load-bearing elements of the facade and the principal load-bearing members, such as, for example, the posts (16) or crossmembers, one first, exterior, i.e. weather-side, thermal partition and a second, interior, i.e. room-side thermal partition. Between the principal load-bearing members there is arranged on the weather-side a covering (2), with adjoining air gap, or an insulating glazing or an insulating covering, and on the room side there is arranged a heat insulation (6), with covering (24), or an insulating glazing. The principal load-bearing members can be connected, on the weather-side, via a poorly heat-conducting structure (18, 12, 14) to the corresponding covering (2), and it comprises at least two spaced-apart individual elements (16, 26) which can be connected to each other via further poorly heat-conducting connections (28). <IMAGE>
Patent DK-0508796-T3 (DK)
Inventor: BOCK MARK G
IPC: A61P1/00
Filed: 1992-04-09
Granted: 1998-10-26
Abstract: Benzodiazepine analogs of the formula: <CHEM> are disclosed which are antagonists of gastrin and cholecystokinin (CCK).
Patent DK-0514528-T3 (DK)
Inventor: INGLETT GEORGE E
IPC: A23L33/00
Filed: 1991-11-26
Granted: 1996-06-10
Abstract: Soluble dietary fiber products can be prepared by hydrolyzing an oat or barley substrate with an  alpha -amylase and recovering the soluble fraction. The recovered material comprises maltodextrins and beta -glucans and/or pentosans as the dietary fiber with small amounts of protein lipid and ash. These compositions are colorless and devoid of inherent undesirable flavors, and are, therefore, suitable for use in a variety of foods. By employing centrifugal separation at a temperature substantially below the hydrolysis temperature, the amounts of lipids and proteins in the dietary fiber product can be reduced, thereby further improving product quality.
Patent DK-0585229-T3 (DK)
Inventor: GHANBARI EBRAHIM
IPC: H01J37/32
Filed: 1992-01-21
Granted: 1995-12-27
Abstract: An electron cyclotron resonance plasma generator is provided in a semiconductor wafer plasma processing apparatus and cluster tool module, particularly for use in soft etching. The generator generates a uniform plasma by rotating a plasma producing resonance supporting magnetic field about the axis of a resonance cavity within the vacuum chamber of a plasma processor. The rotated field preferably is a single-cusp or multicusp field. Gas uniformly flows into and through the cavity from a gas distribution shower. Microwave energy is evenly divided and coupled into the cavity in a TM01 mode by a plurality of axially and radially aligned loops.
Patent DK-0641316-T3 (DK)
Inventor: DEKEYSER MARK A
IPC: C07C311/49
Filed: 1992-11-17
Granted: 1997-08-11
Abstract: Compounds having the structural formula    <IMAGE>ined in the specification are disclosed. The compounds of this invention are effective for controlling mites, nematodes, rice planthopper, tobacco budworm, and southern corn rootworm. Methods for making these compounds are also set forth.
Patent DK-0568833-T3 (DK)
Inventor: KATO HIROYUKI
IPC: C07K14/00
Filed: 1993-04-08
Granted: 2000-09-18
Abstract: A novel human antithrombin III (AT III) mutant having a high antithrombin activity in the absence of heparin and effective in the treatment of thrombotic disorders as an anticoagulant, which is obtained by mutating amino acids at the reactive site and the heparin binding site of human AT III into another amino acids with the use of the recombinant DNA technology with the use of a DNA coding for AT III as a template. A method for mass producing the above-described mutant by incubating a host transformed by an expression vector having the cDNA of the mutant inserted therein.
Patent DK-0555917-T3 (DK)
Inventor: CAIN FREDERICK WILLIAM
IPC: A23G3/34
Filed: 1993-02-05
Granted: 1996-03-18
Abstract: Fat compositions, comprising:     35-80 wt% SUS   less than 5 wt% S3   7-60 wt% (U2S + U3)   less than 40 wt% SSU  whereas: weight ratio <MATH>  S= saturated fatty acids C16-C18  S'= saturated fatty acids C10-C24  U= unsaturated fatty acids C16-C22 are excellent cool-melting, non-temper, non-trans filling fats.
Patent DK-0654167-T3 (DK)
Inventor: LIENAU RICHARD
IPC: H01L27/22
Filed: 1993-08-04
Granted: 1999-07-12
Abstract: A nonvolatile random access memory is disclosed having a substrate (50) carrying separate magnetically polarizable domains (19) each surrounded by a full write loop member (18) and arranged to penetrate the Hall channel (36) of a dual drain FET (16) with its residual magnetic field. The domains are organized in word rows and bit columns, are each written to by a single full write current through the surrounding loop member and each read by a comparator connected to the FET drains (42, 42'). The memory can be fabricated in a variety of forms (e.g. a planar card).
Patent DK-0632039-T3 (DK)
Inventor: ABE TAKAO
IPC: A61P31/04
Filed: 1994-06-30
Granted: 2002-05-13
Abstract: Novel 3-Mercapto-1-(1,3-thiazolin-2-yl)azetidine derivatives represented by formula (IX) below or acid addition salts thereof <CHEM> wherein R is hydrogen, C1-C7 alkyl group which is unsubstituted or substituted by hydroxy, C1-C7 alkoxy or C1-C7 alkoxy-C1-C7 alkoxy group; group -COOR<1> (R<1> is hydrogen or C1-C7 alkyl group); or group -CONR<2>R<3> (R<2> and R<3> are, independently each other, hydrogen or C1-C7 alkyl and a process for producing these compounds.
Patent DK-0694168-T3 (DK)
Inventor: SOLUM NILS OLAV
IPC: G01N33/50
Filed: 1994-03-23
Granted: 1997-07-21
Abstract: PCT No. PCT/GB94/00592 Sec. 371 Date Oct. 4, 1995 Sec. 102(e) Date Oct. 4, 1995 PCT Filed Mar. 23, 1994 PCT Pub. No. WO94/22018 PCT Pub. Date Sep. 29, 1994The present invention provides a method of diagnosing haemostatic disorders in a human or non-human subject wherein the presence and/or concentration of platelet-derived microvesicles in a sample of body fluid of the subject is assessed.
Patent DK-0700294-T3 (DK)
Inventor: DOERNHOEFER WINFRIED
IPC: A61K47/00
Filed: 1994-05-25
Granted: 1999-03-29
Abstract: The invention relates to an injectable solution for intravenous or intramuscular administration to animals with a content, based on 100 ml of solution, of 5 to 25 g of oxytetracycline or doxycycline, each as magnesium complex, 5 to 25 g of polyvinylpyrrolidone, the required amount of an inorganic or organic base to adjust the pH of 5.0 to 9.5, and conventional additives in an aqueous/organic solvent phase, in which the solvent phase consists of 8 to 66 g of N-methylpyrrolidone and/or 2-pyrrolidone, preferably in a mixing ratio of 92:8 to 70:30 by weight, and water, based on 100 ml of solution, and to a process for the production thereof.
Patent DK-0717487-T3 (DK)
Inventor: NOVATI DANIELE
IPC: H02J3/14
Filed: 1995-12-07
Granted: 1999-07-05
Abstract: In the electrical system described, a central control unit (13) sends signals on a data-transmission line (16) to a plurality of peripheral control units (14a, 14b, ... 14n) associated with the electrical sockets (11a, 11b, ... 11n) of the system. The peripheral units in turn receive and send signals on the same line (16). The signals contain address data for the peripheral units and commands for activating and de-activating the sockets. The sockets are activated and de-activated by means of switches (12a, 12b, ... 12n) controlled automatically by the peripheral units according to priority levels which are assigned to them and can be selected on the associated peripheral units, and on the basis of the criterion that, at any moment, the system must be supplied with the maximum power demanded as far as the maximum power available (Pmax) allows. <IMAGE>
Patent DK-0754754-T3 (DK)
Inventor: SHIN SADAHITO
IPC: C12R1/91
Filed: 1995-03-09
Granted: 2001-10-08
Abstract: The present invention provides an FK506 binding protein gene containing a base sequence coding for the amino acid sequence shown under SEQ ID NO:1, in particular such a FK506 binding protein gene containing the base sequence shown under SEQ ID NO:2, a method of producing a recombinant FK506 binding protein through expression of such gene, and the recombinant protein thus produced. The use of the gene of the present invention enables FK506 binding protein expression, and the protein is useful particularly in elucidating the mechanism of immunosuppression in living bodies or in developing or screening out therapeutic agents for autoimmune diseases (e.g. rheumatism, SLE, etc.), among others.
Patent DK-0708831-T3 (DK)
Inventor: TONKS NICHOLAS K
IPC: C12N15/55
Filed: 1995-05-03
Granted: 2003-08-04
Abstract: Novel Type III density enhanced protein tyrosine phosphatases are disclosed and exemplified by human DEP-1 enzyme. Polynucleotides encoding huDEP-1 are disclosed, along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for DEP-1 are also disclosed as useful for modulating the biological activities of DEP-1. <IMAGE>
Patent DK-0781281-T3 (DK)
Inventor: KARAM OMAR APPARTEMENT
IPC: A61P25/00
Filed: 1995-09-14
Granted: 2002-04-15
Abstract: The present invention provides  beta -carboline derivatives useful as components of cosmetic, medicinal, and pharmaceutical compositions. The medicinal and pharmaceutical compositions can be used to induce hypnotic activity in a subject. Methods of producing the  beta -carboline derivatives are provided as well.
Patent DK-0792152-T3 (DK)
Inventor: SPICER DARCY V
IPC: A61P15/00
Filed: 1995-11-21
Granted: 2004-07-12
Abstract: Compositions and methods for use in treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent Äe.g., progesterone (progestin, progestogen, gestagen) antagonist or progesterone synthesis inhibitorÜ administered over a first period of time is combined with an effective amount of a progestogen for a second period of time. The antiprogestational agent is selected from single agents or mixture thereof. The progestogen is selected from single agents or mixtures of natural or synthetic progestogens. The formulations are effective as contraceptive agents and for treatment of benign gynecological disorders including uterine fibroids, premestrual syndrome, dysfunctional uterine bleeding, polycystic ovarian syndrome and endometriosis.
Patent DK-0860048-T3 (DK)
Inventor: ANDREW WILLIAM GREEN
IPC: H02M7/217
Filed: 1996-10-24
Granted: 2003-10-06
Abstract: PCT No. PCT/NZ96/00119 Sec. 371 Date Sep. 1, 1998 Sec. 102(e) Date Sep. 1, 1998 PCT Filed Oct. 24, 1996 PCT Pub. No. WO97/17753 PCT Pub. Date May 15, 1997An AC-DC power supply system for receiving a three phase mains supply and outputting a transformed DC supply. The power supply unit has a rectifier circuit (30) providing an output to a three phase inverter circuit (40) to generate a pseudo AC three phase output of higher frequency than the AC supplied to the rectifier circuit (30). A three phase transformer (60) receives the pseudo AC three phase output and transforms the output to a three phase rectifier circuit (70) to generate the output DC supply. The inverter circuit (40) provides a three leg bridge structure with each leg having a switching device one of which is used to provide a phase reference whereas the other two legs control the relative phase shift on each leg to reduce the phase shift relative to the phase reference on one leg and increase the phase shift relative to the phase reference on the other leg.
Patent DK-0871434-T3 (DK)
Inventor: JEPSEN SVENN KLUEVER
IPC: A61K9/16
Filed: 1996-12-23
Granted: 2002-01-07
Abstract: Modified release pharmaceutical composition and method for the treatment of inflammatory bowel diseases (IBD) such as Crohn's disease and Colitis Ulcerosa, said compositions comprising as active the ingredient 5-aminosalicyclic acid (5-ASA), and being adapted for modified and targeted release so as to obtain a clinically important localized effect profile of 5-ASA by means of releasing an appropriate amount of 5-ASA in both the small and large bowel.
Patent DK-0798071-T3 (DK)
Inventor: POMPEI PHILIPPE
IPC: B23P21/00
Filed: 1997-03-25
Granted: 2003-03-17
Abstract: An installation for processing gas cylinder valves, each valve comprising a collar (2) extended, on the side opposite to an operating knob (3) by a threaded end (4) for its attachment to a cylinder, comprises a valve (1) conveyor circuit for routing them towards one or several processing devices. This conveyor circuit has a horizontal mobile conveyor surface (6) on which individual valve holders (7) are positioned, each valve holder (7) comprising a plate (8) for receiving the collar (2) of a valve to be conveyed, this plate (8) comprising a bore (9) for the passage of the threaded end (4). The valve holder (7) comprises support means (10) for the plate, destined to rest on the conveyor surface (6) and to hold the plate (8) at an elevation such that the lower extremity (11) of the threaded end (4) is situated above the conveyor surface (6). <IMAGE>
Patent DK-0805153-T3 (DK)
Inventor: LISTON DANE R
IPC: C07D261/02
Filed: 1997-04-15
Granted: 2002-03-18
Abstract: Muscarinic receptor agonists of the formula:- <CHEM>  wherein   X is NR<4>R<5>, (C1-C10)alkyl or optionally substituted (C3-C10)cycloalkyl,   n is an integer from one to three;   m is an integer from one to three;   p is an integer from one to three;   Y is N or CH; Z is NR<7>R<8>, optionally substituted (C3-C10)cycloalkyl, (C1-C10)alkyl, pyridyl or optionally substituted phenyl;   R<2> is optionally substituted phenyl;   R<3> is optionally substituted phenyl; R<4> and R<5> are independently (C1-C10)alkyl or R<4> and R<5> taken together with the nitrogen atom to which they are attached form a (five to nine)-membered saturated heterocyclic ring.   R<6> is hydrogen or (C1-C6)alkyl; and R<7> and R<8> are independently (C1-C10)alkyl or R<7> and R<8> taken together with the nitrogen atom to which they are attached form a (five to seven)-membered saturated heterocyclic ring.
Patent DK-0951789-T3 (DK)
Inventor: RANTANEN KARI
IPC: H04M3/533
Filed: 1997-02-20
Granted: 2005-08-15
Abstract: Disclosed is a system and method to transmit data to a company's data system by a mobile phone connected to a mobile communications network, and receive an acknowledgment to the same mobile phone from the company's data system. A preset target number dialed by a mobile phone is directed to an intelligent network center. The target number is decoded into data which is transmitted to a company's data system during the connection. The intelligent network center uses the caller's identifying number to check whether the caller is entitled to use the service, and to check to which information system of which company the data has been sent. The intelligent network center transmits a telecommunications network signaling the target number, caller's number and address of the company's to a voice server computer capable of identifying telephone numbers and formulate voice messages. The voice server converts the target number into data and transmits the data and the caller's number to the company's data system using a data network protocol. The company's data system stores the data in the data system and formulates a return message, which includes an acknowledgment of the received data and further a possible additional information, and transmits it to the voice server using the data network. The voice server transmits using the mobile communications network the return message either as a GSM short message or as a voice message to the mobile station which transmitted the data code, or as a pager message to a desired pager device.
Patent DK-0968607-T3 (DK)
Inventor: BENARDEAU CHRISTIAN
IPC: H04N21/418
Filed: 1997-04-25
Granted: 2003-06-10
Abstract: A smartcard for use with a receiver of encrypted broadcast signals comprises a microprocessor for enabling or controlling decryption of said signals. A memory is coupled to the microprocessor. The microprocessor is adapted to enable or control the individual decryption of a plurality of such signals from respective broadcast suppliers of such signals by means of respective dynamically created zones in the memory, the dynamically created zones each being arranged to store decryption data associated with a respective one of said broadcast suppliers. <IMAGE>
Patent DK-0901633-T3 (DK)
Inventor: GOEDERT MICHEL
IPC: G01N33/68
Filed: 1997-05-20
Granted: 2003-06-16
Abstract: A method of screening an agent for potential use in the treatment of Alzheimer's disease, comprises reacting, in the presence of the agent, tau protein with a suitable sulphated carbohydrate under appropriate conditions to form filaments, and monitoring for the presence of filaments. Tau protein and sulphated carbohydrate, e.g. sulphated glycosaminoglycan, will react under appropriate conditions to form filaments, either paired helical filaments or straight filaments. If filament formation is affected when the reaction is carried out in the presence of an agent being screened, this is possibly due to an interfering, inhibiting or blocking effect of the agent. An agent which inhibits assembly of PHFs in vitro may also have an inhibiting effect in vivo and thus have potential therapeutic value in delaying the dementing effects of Alzheimer's disease. The invention can thus provide a screen to identify agents worthy of further investigation for use in the treatment of Alzheimer's disease.
Patent DK-0939086-T3 (DK)
Inventor: VAN DER TUIN EVERHARDUS
IPC: A61L31/04
Filed: 1998-02-27
Granted: 2004-04-13
Abstract: A process for producing crosslinked hyaluronic acid (HA) or a salt thereof is disclosed, in which an aqueous solution of HA is crosslinked with divinyl sulphone (DVS) at a pH between 8 and 11 using a molar ratio of DVS/HA between 1 and 10%. The process results in a viscous aqueous solution of crosslinked hyaluronic acid or salt thereof, which is suitable for viscosupplementation of joints, especially for racing horses.
Patent DK-1015352-T3 (DK)
Inventor: KATZNER LEO D
IPC: B65D75/34
Filed: 1998-04-01
Granted: 2008-01-14
Abstract: The invention is a blister package for containing frangible dosage forms while protecting the dosage forms from damage during transport and opening of the package. A blister sheet defines one or more recesses in which frangible dosage forms are disposed and a peelable sheet of lidding material overlies the recesses to cover the dosage forms therein. The dosage forms engage each recess to prevent shifting of the dosage form during transport. Indicia on the blister package directs the user with regard to the procedure for opening the package without damaging the dosage forms. Unsealed areas in the package, which provide a portion of lidding material which the user can grab to peel open the package, are provided with dimples which hide the grabable portion of lidding material from children.
Patent DK-1087758-T3 (DK)
Inventor: TUCKER MARK RUPERT
IPC: A61K9/70
Filed: 1999-04-14
Granted: 2005-01-24
Abstract: A continuous process for forming a transdermal patch which comprises the steps of: continuously feeding a strip of material comprising a layer of permeable membrane; continuously feeding into close proximity and in face-to-face relationship with the first strip a second strip formed of impermeable backing material; passing the first and second strips together through a filling and sealing station in which the material containing an active substance is introduced between the strips and pouches are formed by first sealing devices which seal the strips together in a longitudinal direction of the strips and second sealing devices which seal the strips together in a transverse direction of the strips; the size of the pouches being adjusted by adjusting the number position and/or frequency of operation of the first sealing devices and/or by adjusting the number position and/or frequency of operation of the second sealing devices.
Patent DK-1116368-T3 (DK)
Inventor: PERKINS RODNEY
IPC: H04L9/08
Filed: 1999-09-21
Granted: 2005-10-17
Abstract: A data transfer system comprises a sender, receiver and a key facility. The sender encrypts data and splits it into parts. One part is further encrypted for a key facility. The parts are sent to the receiver. The receiver requests decryption of the part encrypted for the key facility and the receiver is then able to decrypt the complete data.
Patent ES-2292387-T3 (ES)
Inventor: RUEGER JOHANNES-JOERG
IPC: F02M47/02
Filed: 2000-04-01
Granted: 2008-03-16
Abstract: The invention describes a method and an apparatus for charging a piezoelectric element, for example, used as an actuator in a fuel injection system of an internal combustion engine. The method and apparatus are characterized in that the piezoelectric element is activated by an activation voltage, which is corrected for the piezoelectric element's temperature. The piezoelectric element's temperature is determined by loss efficiency. <IMAGE>